Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous human umbilical cord blood cells
- Development stage
- Unknown
- Lead developer
- Memorial Hermann Health System
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Autologous human umbilical cord blood (hUCB) cell therapy involves the intravenous infusion of a patient's own cord blood, which was harvested and cryopreserved at birth. In the context of perinatal arterial ischemic stroke (AIS), this therapy is being evaluated for its safety and potential to improve functional outcomes in children. The cells are hypothesized to migrate to the site of neonatal brain injury and facilitate repair through the release of anti-inflammatory cytokines and neurotrophic factors, thereby reducing secondary neuronal loss and promoting neuroplasticity. This specific research is led by Aryn Knight at the University of Texas Health Science Center at Houston.
- Other names
- autologous human cord blood derived stem cellshUCB cellsautologous human umbilical cord blood
Beyond the preview
Go deeper on autologous human umbilical cord blood cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous human umbilical cord blood cells.